Related Experiment Video
Updated: May 19, 2026

10:51
Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System
Published on: April 23, 2021
An "elite hacker": breast tumors exploit the normal microenvironment program to instruct their progression and
Aaron Boudreau1, Laura J van't Veer, Mina J Bissell
1Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA. Aaron.Boudreau@ucsf.edu
Cell Adhesion & Migration
|August 7, 2012
Summary
The "War on Cancer" has advanced tumor genetics, but the breast cancer microenvironment is key. Understanding normal mammary gland biology and its vulnerabilities may offer new therapeutic targets.
Area of Science:
- Oncology
- Cell Biology
- Developmental Biology
Background:
- Significant progress in understanding tumor genetics has been made since the
- The role of the stromal microenvironment in cancer, particularly breast cancer, is increasingly recognized.
- Breast cancer progression shares similarities with normal mammary gland development, including shared molecular, cellular, and microenvironmental influences.
Purpose of the Study:
- To review cellular and molecular interactions within the normal mammary gland microenvironment.
- To present evidence of similar, albeit exaggerated, biological processes in breast cancer progression.
- To explore the potential of targeting microenvironmental signaling for therapeutic benefit.
Main Methods:
- Review of existing literature on mammary gland development and breast cancer biology.
- Analysis of cellular and molecular interactions within the tumor microenvironment.
- Examination of multigene signatures in relation to microenvironmental signaling.
Main Results:
- Normal mammary gland development relies on specific heterotypic cellular and molecular interactions within the microenvironment.
- Breast cancer progression, especially the transition to invasive disease, mirrors normal development but in an imbalanced manner.
- Multigene signatures used to predict cancer outcomes may largely reflect signals from a heterogeneous microenvironment.
Conclusions:
- Understanding the normal mammary gland microenvironment and its vulnerabilities is crucial for developing targeted breast cancer therapies.
- The tumor microenvironment plays a critical role in breast cancer progression.
- Exploiting the signaling from the heterogeneous microenvironment presents a potential therapeutic strategy.
More Related Videos
Related Concept Videos
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

